serum + salivary LDSST by Ceccato, Filippo
Salivary LDSST in suspected AI, Endocrine Connections EC-21-0220, supplementary material, page 1 
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Supplementary figure 1. Passing-Bablok regression between serum F and salivary F (A: y=0.02x+0.04, r=0,72, p<0.001) and E (B: y=0.08x+1.17, r=0,73, p<0.001) 5 
in patients with central AI, for both basal and post-synacthen samples (n=74). 6 
 7 
 8 
  9 
Salivary LDSST in suspected AI, Endocrine Connections EC-21-0220, supplementary material, page 2 
 
Supplementary figure 2. Passing-Bablok regression between serum F and salivary F (A: y=0.06x-0.70, r=0.71, p<0.001) and E (B: y=0.11x-4.02, r=0.67, p<0.001) 10 
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Supplementary figure 3. Passing-Bablok regression between serum F and salivary F (A: y=0.07x-12.71, r=0.66, p<0.001) and E (B: y=0.13x-6.39, r=0.70, p<0.001) 16 
in patients with a normal HPA axis, for both basal and post-synacthen samples (n=212) 17 
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Supplementary figure 4: ROC curves of salivary F and E levels, before and after LDSST, in adrenal sufficient patients (n=137) vs those with adrenal insufficiency 21 
(n=37). The best thresholds are reported in the manuscript (table 4). Panel a: salivary F0; panel b: salivary F30LDSST; panel c: salivary E0; Panel d: salivary E30LDSST.22 
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Supplementary figure 5: Distribution of patients by our calculated threshold for salivary cortisol (F). AS: adrenal sufficient patients; AI: adrenal insufficiency; 24 
HPA: hypothalamic pituitary adrenal; RAS: relative adrenal sufficiency. 25 
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